Follow the 株式会社 カイオム・バイオサイエンス stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares are quoted on JP JP, under the supervision of EDINET (Japan FSA). Market capitalisation: €4.9bn. The latest transaction was reported on 5 April 2024 (Holding update). Among the most active insiders: Barclays Bank PLC. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Kaiohm Bioscience is a Japanese company specializing in biotechnology. It is listed on the XTKS market.